181 related articles for article (PubMed ID: 172392)
61. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
King LE; Solomon SS; Hasimoto K
J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964
[TBL] [Abstract][Full Text] [Related]
62. Activities of 3':5' cyclic nucleotide phosphodiesterases in the superior cervical ganglion of rat: characterization, compartmentalization and observations in young and old animals.
Giorgi M; Squitti R; Bonsi P; Paggi P; Toschi G
Neurochem Int; 1994 Nov; 25(5):493-500. PubMed ID: 7849578
[TBL] [Abstract][Full Text] [Related]
63. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
Donnelly TE
Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
[No Abstract] [Full Text] [Related]
64. Juvenile hormone regulation of CYCLIC AMP and cAMP phosphodiesterase activity in Oncopeltus fasciatus.
Everson RD; Feir D
J Insect Physiol; 1976; 22(6):781-4. PubMed ID: 181493
[No Abstract] [Full Text] [Related]
65. Epiphyseal cartilage cyclic nucleotide phosphodiesterase: partial purification and kinetic characteristics of multiple enzymes.
Ishikawa Y; Newcombe DS
Proc Soc Exp Biol Med; 1976 May; 152(1):105-10. PubMed ID: 177990
[TBL] [Abstract][Full Text] [Related]
66. Cylic nucleotide phosphodiesterase in silkworm. Characterization of cyclic GMP phosphodiesterase.
Morishima I
Biochim Biophys Acta; 1975 Dec; 410(2):310-7. PubMed ID: 1092
[TBL] [Abstract][Full Text] [Related]
67. Cyclic nucleotide phosphodiesterases in dystrophic rat retinas: guanosine 3',5' cyclic monophosphate anomalies during photoreceptor cell degeneration.
Lolley RN; Farber DB
Exp Eye Res; 1975 Jun; 20(6):585-97. PubMed ID: 168094
[No Abstract] [Full Text] [Related]
68. [Phosphodiesterase characteristics of the fat cells in spontaneous hypertension in rats].
Reznikova MB; Postnov IuV
Kardiologiia; 1980 Sep; 20(9):72-6. PubMed ID: 6252365
[TBL] [Abstract][Full Text] [Related]
69. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
Goff AK; Major PW
FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
[No Abstract] [Full Text] [Related]
70. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
71. Effect of dexamethasone on adenosine 3',5'-monophosphate content and phosphodiesterase activities in 3T3-L1 adipocytes.
Elks ML; Manganiello VC; Vaughan M
Endocrinology; 1984 Oct; 115(4):1350-6. PubMed ID: 6207010
[TBL] [Abstract][Full Text] [Related]
72. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
Davis CW
Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
[TBL] [Abstract][Full Text] [Related]
73. Cyclic nucleotide phosphodiesterase activity in normal and neoplastic rat mammary cells grown in monolayer culture.
Cohen LA; Straka D; Chan PC
Cancer Res; 1976 Jun; 36(6):2007-12. PubMed ID: 178439
[TBL] [Abstract][Full Text] [Related]
74. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
75. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
Hidaka H; Asano T; Shimamoto T
Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
[TBL] [Abstract][Full Text] [Related]
76. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
[TBL] [Abstract][Full Text] [Related]
77. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
Erneux C; Van Sande J; Dumont JE; Boeynaems JM
Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
[TBL] [Abstract][Full Text] [Related]
78. Changes in calmodulin concentration and cyclic 3',5'-nucleotide phosphodiesterase activity in skeletal muscle of hyper- and hypothyroid rats.
Mano T; Iwase K; Yoshimochi I; Sawai Y; Oda N; Nishida Y; Mokuno T; Kotake M; Nakai A; Hayakawa N
J Endocrinol; 1995 Aug; 146(2):287-92. PubMed ID: 7561641
[TBL] [Abstract][Full Text] [Related]
79. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
Sobolev AS; Rybalkin SD
Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
[TBL] [Abstract][Full Text] [Related]
80. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
